| First Author | Noh K | Year | 2017 |
| Journal | Cell Rep | Volume | 21 |
| Issue | 10 | Pages | 2785-2795 |
| PubMed ID | 29212026 | Mgi Jnum | J:254931 |
| Mgi Id | MGI:6103927 | Doi | 10.1016/j.celrep.2017.11.020 |
| Citation | Noh K, et al. (2017) Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis. Cell Rep 21(10):2785-2795 |
| abstractText | Angiogenesis inhibitors are important for cancer therapy, but clinically approved anti-angiogenic agents have shown only modest efficacy and can compromise wound healing. This necessitates the development of novel anti-angiogenesis therapies. Here, we show significantly increased EGFL6 expression in tumor versus wound or normal endothelial cells. Using a series of in vitro and in vivo studies with orthotopic and genetically engineered mouse models, we demonstrate the mechanisms by which EGFL6 stimulates tumor angiogenesis. In contrast to its antagonistic effects on tumor angiogenesis, EGFL6 blockage did not affect normal wound healing. These findings have significant implications for development of anti-angiogenesis therapies. |
